Month: September 2025

Letter to the Editor

Increasing the dosing interval of dupilumab in patients with severe asthma and chronic rhinosinusitis with nasal polyps

/ by edra

Read more »

Review

Eosinophilic ascites and eosinophilic gastrointestinal diseases

/ by edra

Background. Eosinophilic ascites (EA) is characterised by a high eosinophil count in the ascitic fluid and, although very rare, is mainly caused by eosinophilic gastrointestinal diseases (EGIDs), parasitic infections, and hypereosinophilic syndrome (HES). Symptoms caused by EGIDs are varied and depend on the gastrointestinal tract affected as well as the layer(s) involved; typically, EA implies […]

Read more »

Editorial

Pollen-induced asthma: a unique model of mild to moderate asthma

/ by edra

Read more »

Original Article

Demographic and clinical characteristics of chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience

by edra

Background. Chronic spontaneous urticaria (CSU) is a common disorder characterized by the recurrence of wheals and/or angioedema for more than 6 weeks. About 35% of patients experience wheals and angioedema (AE-CSU) and around 6% of patients only present angioedema, also known as chronic histaminergic angioedema (CHA). As few data comparing CHA and AE-CSU are published, […]

Read more »

Letter to the Editor

Allergy to peanuts and peanut oil: a new severe italian phenotype?

/ by edra

Read more »

Position Paper

Pollen-induced asthma: diagnostic and therapeutic implications

/ by edra

Evidence supports the hypothesis of pollen-induced asthma as a specific asthma phenotype, with defined clinical features and tailored pathways for its clinical management. The probability of diagnosis varies significantly in the pollen season, in which allergic patients are symptomatic, as compared to asymptomatic periods outside the pollen season. In this context, a novel diagnostic scheme […]

Read more »

To top